Azimuth Capital Investment Management LLC Viatris Inc Transaction History

Azimuth Capital Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $7,829 - $8,931	-868 Reduced 2.2%	38,538 $384,000
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $138,864 - $185,052	-15,094 Reduced 27.7%	39,406 $379,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $9,592 - $12,716	-1,100 Reduced 1.98%	54,500 $606,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $37,312 - $48,972	-4,400 Reduced 7.33%	55,600 $474,000
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $597,000 - $736,200	60,000 New	60,000 $628,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Azimuth Capital Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Azimuth Capital Investment Management LLC with notifications on news.